# Renal Pelvic Denervation Pilot Trial

> **NCT07005050** · NA · RECRUITING · sponsor: **Verve Medical, Inc** · enrollment: 60 (estimated)

## Conditions studied

- Uncontrolled Hypertension

## Interventions

- **DEVICE:** RPD
- **DRUG:** Active hypertension medical therapy

## Key facts

- **NCT ID:** NCT07005050
- **Lead sponsor:** Verve Medical, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2026-10-30
- **Final completion:** 2029-03-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07005050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07005050, "Renal Pelvic Denervation Pilot Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07005050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*